Biogen (NASDAQ:BIIB) reported 3/31/2019 earnings this Morning, coming in at $6.98 per share, beating Wall Street’s estimates of $6.88 per Share. Revenue for the quarter came in at $3.49 billion beating analyst estimates of $3.38 billion
Recent Trading for Biogen (NASDAQ:BIIB)
Shares of Biogen closed the previous trading session at with 230 shares trading hands.